clinical 1,146 words KG: Terazosin
Contents

Terazosin for Cardiac Autonomic Changes in Early Parkinson's Disease (NCT04386317)

No AI portrait yet

Knowledge Graph

Related Hypotheses (5)

Multi-Modal Stress Response Harmonization
Score: 0.76
Circadian-Synchronized Proteostasis Enhancement
Score: 0.74
Vagal Afferent Microbial Signal Modulation
Score: 0.62
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.48
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.51

Related Analyses (17)

Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40

Knowledge Graph (3 edges)

Terazosin activates PGK1
Terazosin suppresses Seizure Severity
Terazosin treats Seizure Comorbidity In Alzheimer'S Disease

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)